Skip to main content
spacbrain

Artius II Acquisition Inc.

AACB · Nasdaq · AI/Tech

Trust settledFinished

NO ACTION REQUIRED

Nothing left to do

The cash went back to shareholders and the company wound up. There is no deadline left to miss.

Trust settled

There is no line to draw here. This vehicle has finished: the cash was paid back or spent closing the deal, so the last filed figure describes an account that no longer exists and would be a floor under nothing.

$10.59
10 Aug13 closes27 Aug

SpacBrain’s read

Trust settled

The trust was liquidated and paid back to holders pro rata — the floor was honoured and the SPAC has wound up, so there is nothing left to claim.

Change on the last daily close0.0% day

$10.56 is the last cash-per-share figure filed while this was still a SPAC. That account has since been settled, so it is history rather than a floor under this price.


In plain terms

What it is
A $220M SPAC from Artius II Acquisition Partners LLC, listed on Nasdaq in February 2025. Each unit put $10.00 into the shareholders' cash account at listing; by the end it held $10.56 a share — interest earned on the account, plus any payments the sponsor made to extend the deadline, spread over the shares that never cashed out.
What it's doing now
It never completed a purchase. The company wound up and the cash in the account went back to shareholders — the ordinary ending when a SPAC runs out of time. No agreed deal for it is on file with us, so we cannot say whether one was ever announced and later fell through.
What you should know
This SPAC has finished. The cash was paid back to shareholders and the company wound up, so there is nothing left to claim — the money went where the charter said it would.

At a glance

Where it stands
Liquidated
Deal
none — it wound up and returned the cash instead
Industry
AI/Tech
What it set out to buy: AI/Tech
Deal value
no deal to value — it wound up instead
Price vs cash at settlement
$10.59 vs $10.56
$0.03 above the last filed cash figure — the account has since been settled
Cash in trust when it settled
$232.2M
the last trust total filed while this was still a SPAC — the account has since been paid out or used to close the deal
IPO
14 February 2025
$220M raised · 100.0% of each $10 unit into trust
Headquarters
3 COLUMBUS CIRCLE, NEW YORK, NY, 10019
registered in the Cayman Islands
Lead underwriter
Santander US Capital Markets LLC
Key officers
SIM Boon (CEO, CFO) · Stein John Stanley III (Director) · COSTELLO KEVIN (Director)
Listed securities
AACB common · AACBU unit $10.70 · AACBR right $0.01
Cash held per share$10.56

As last filed, 30 June 2026. That was the account's last filed value before it was settled — the company does not hold it now.

source: 10-Q acc 0001140361-26-031434

Price against the cash
vs last filed NAV
0.3%above cash
$10.56, 10-Q as of Jun 30, 2026, acc 0001140361-26-031434

Measured against the last filed cash figure. No accrued estimate is published for this SPAC, so no second reading is shown.

Next date that mattersno dated event on file

Nothing dated is on file. That is an absence in the record, not a statement that nothing is coming.

Yield to redemption

Nothing left to redeem — no yield to compute.

This SPAC has finished — its trust was paid back or used to close the deal, so there is nothing left to redeem and no yield to compute. A yield to redemption is a claim that you can hand these shares back for the trust cash. That account is closed, so this page will not print a number here.


What happened to the cash

The reasoning behind the verdict above, in the order the filings establish it.

  1. The trust was liquidated and paid back to holders pro rata — the floor was honoured and the SPAC has wound up, so there is nothing left to claim.
  2. $10.56 a share is the last cash figure filed while this was still a SPAC. It is a record of what the account held, not money anyone can ask for now.

What has happened, and what is coming

1 dated milestone

Every dated step from the day it listed to the next date you may have to act on. Where you have to do something, the day your broker needs the instruction is marked too.

  1. 14 February 2025IPOpassed

    $220M raised into trust


The score

deterministic, from filed fields

AACB is not in the scored universe, so no score is shown. A withheld score is a fact about the record, not a verdict about the company.

Asymmetric return scoreNo cash-per-share figure is on file, and the score measures the price against it. The dial stays empty rather than modelling a floor.

The score is only published for names that carry both a price and a filed cash-per-share figure — 292 of the tracked fleet today. The rest keep an empty dial rather than a modelled one, and fill in by themselves as the fields land.

See the names that are scored, and how


The company

from SEC filings
Read the full profile

A $220 million SPAC that listed on Nasdaq in February 2025 and is still shopping — its Q2 2026 10-Q (filed August 2026) shows no agreement with any target. The IPO sold 22 million units at $10.00, and the full $220 million sits in trust at $10.00 per unit. It is the second Artius vehicle; shares trade as AACB with rights under AACBR.


Material findings

from the full read of every filing

Every document this company files gets read whole — body and exhibits. These are the ones the read flagged as material, newest first, each citing its filing.

  • This filing terminates the search for a target acquisition and triggers the mandatory trust payout mechanics for public investors. It dictates that Public Shareholders will receive a pro-rata cash distribution from the trust, subject to statutory creditor protections, tax withholdings, and a capped $100,000 withdrawal for dissolution costs. Conversely, rights holders face a total loss with no recourse. Because the exact per-share cash amount depends on the final, uncomputed trust balance at redemption, investors must track subsequent procedural announcements for the record date, filing deadlines, and precise redemption price.

  • Shareholders face a compressed timeline to the August 14, 2026 liquidation deadline, intensifying pressure on management to demonstrate substantive target diligence before the extension triggers. The July 23, 2026 Treasury maturity creates immediate compliance risk if funds are not rolled over to continue accruing interest for shareholder benefit. Converting the Sponsor Working Capital Loan to cash-only limits potential post-deal dilution from convertible debt but removes equity upside incentives for the Sponsor relative to prior terms. Management’s heavy reliance on $ 4,165,986 in trust interest to cover $ 3,356,749 in H1 2026 operating costs highlights extreme fragility in external liquidity; with only $ 21,231 in operating cash and a $ 4,547,832 working capital deficit, any disruption to interest accrual or unexpected due diligence spend threatens ongoing search operations and triggers the stated going concern warning. Deferred liabilities of $ 6,600,000 (underwriting) and $ 6,000,000 (advisory) remain payable only upon deal completion, aligning sponsor/underwriter payouts with successful execution but underscoring the substantial capital hurdles facing a prospective target acquisition.

  • The trust accretion directly increases the maximum potential return for shareholders upon redemption or liquidation. Removing the conversion feature from the working capital debt eliminates future capitalization dilution risk but does not alleviate the severe near-term liquidity gap. With zero operating revenue, a monthly burn rate exceeding $180,000, and a fixed closing deadline of August 14, 2026, these figures heighten the going concern warning and force management to aggressively pursue or secure a definitive business combination agreement before mandatory dissolution triggers.

  • The conversion feature removal restructures the working capital facility into fixed-cash debt, clarifying payout hierarchy and eliminating equity dilution complications at merger close, while the explicit trust waiver shields public shareholder redemption value from note servicing. However, the Nasdaq extension establishes a rigid August 31, 2026, compliance deadline that runs parallel to the business combination search. As stated in the filing, there is no assurance the Company can repopulate the holder base to 300 public holders by that date, meaning listing suspension risk persists regardless of deal advancement. If delisting occurs before resolution, trading accessibility and liquidity for public warrants and Class A ordinary shares deteriorate. The document confirms active sponsor funding of ongoing operations while highlighting the execution friction between exchange regulatory timelines and SPAC deal progression.

  • The $10.37 per-share trust accumulation modestly increases the absolute cash pool for redemptions or a de-SPAC transaction relative to the initial proceeds, but does not change the structural mechanics of the redemption deadline or the voting thresholds. The reported working capital deficit highlights ongoing operational dependency on the Sponsor, reinforced by the newly disclosed $1,000,000 working capital note. Because the audit opinion flags going concern risk against the August 2026 deadline, public shareholders face heightened binary outcomes: either a definitive agreement is signed by mid-2026 to secure the February 2027 extension, or the company proceeds to mandatory liquidation near January 2027. Close attention is warranted on whether management exercises the extension mechanism or faces insolvency pressures from the current deficit.

  • The zero-interest working capital advance preserves the existing $10.56 trust value per share for redemption scenarios by funding operations through sponsor credit, though conversion features create latent dilution upon deal completion or liquidation. The Nasdaq deficiency notice is operationally critical: falling below 300 public holders triggers delisting proceedings that can abruptly curtail the SEARCHING phase. Loss of exchange listing typically forces accelerated redemption timelines, complicates sponsor negotiation leverage, and may require restructuring the business combination process to bypass public market requirements before the 180-day cure period expires.

Show 21 more material filings
  • This filing updates the financial runway and reaffirms the strict redemption and dissolution timeline without advancing deal progress. The material disclosure centers on the substantial fixed pre-combination costs ($6,000,000 advisory fee plus monthly administrative fees) draining non-trust liquidity, highlighting the financial pressure to secure a de-SPAC transaction before the August 14, 2026 cutoff or face mandatory dissolution.

  • Filed 13G amendments typically indicate institutional position adjustments, portfolio rebalancing, or threshold recalibrations, but the truncated excerpt lacks the operational pages required to verify actual share movements, control assertions, or tender intentions. No claims regarding customers, revenues, market sizing, strategic direction, technology, partnerships, litigation, or personnel are present in the text. Because no factual assertions or metrics are disclosed in the snippet, no speaker, officer, or third party can be attributed as their source. While the submission confirms that AQR’s arbitration and advisory arms maintain visibility over Artius II Acquisition Inc. during its SEARCHING phase, the absence of quantified holdings or intent language means the filing does not independently shift redemption mechanics, alter trust accounting, trigger extension timelines, or signal deal progress. Investors should await the complete Schedule 13G/A package or accompanying Form 8-K disclosures to determine whether this amendment aligns with aggregate SPAC warrant/certificate trading, proxy scheduling, or sponsor commitment updates.

  • The explicit statement of zero substantive discussions keeps the standard 18-month completion window (terminating approximately August 14, 2026) active without extension mechanisms, maintaining full redemption clock pressure. The documented trust value of $10.16 per share sets the precise baseline for public shareholder redemptions and reflects realized interest accretion since the February 14, 2025 IPO. The recording of a $6,000,000 advisory fee and $6,600,000 deferred underwriting obligation materially increases fixed payout burdens; these commitments reduce future liquidity available for acquisitions or intensify potential redemption outflows. The combination of zero deal progress, high deferred compensation, and a filed going concern warning signals heavy reliance on executing a transaction before operating runway depletes.

  • Per the filing, the redemption mechanism and timeline are now fixed: the company has an 18-month completion window from the February 14, 2025, closing, extendable to 24 months if a definitive business combination agreement is executed within the initial 18 months. Redemptions will be priced at the aggregate trust account balance divided by outstanding public shares, calculated two business days prior to consummation, plus accrued interest less taxes, or upon liquidation if the window expires. The sponsor contractually waived redemption rights for founder and private placement shares and agreed to vote those shares in favor of any initial business combination, though the company notes it cannot verify whether the sponsor possesses sufficient non-security assets to satisfy its indemnification obligation should third-party claims reduce the trust below the lesser of $10.00 per share or the actual per-share trust balance. The $6,600,000 deferred underwriting discount and $6,000,000 advisory fee create hard liabilities payable solely from trust proceeds upon a successful combination, directly reducing distributable trust value. WithumSmith+Brown, PC expressly qualified the financials with a going concern warning, stating the company lacks financial resources to sustain operations for a reasonable period (one year) without completing a business combination, meaning pre-combination burn must be funded externally or through convertible working capital loans up to $1,500,000. The absence of operating revenue, combined with the $11,888,147 shareholders’ deficit and the auditor’s emphasis on substantial doubt, signals that public shareholder return is entirely dependent on executing a transaction within the disclosed completion window or negotiating an extension.

  • Investors must calibrate expectations around a hard 18-to-24-month execution horizon where extension votes may carry hidden trust-funding demands, altering the traditional time-value calculation for redemption. The 15% redemption cap for concentrated holders fundamentally reshapes vote-buying economics and target negotiation leverage.

  • This filing locks in the economic architecture and temporal constraints governing all public shareholders. The 18-to-24-month hard deadline dictates the absolute outer limit for redemption calculations and deal speculation. By conditioning the entire $6,000,000 deferred underwriting payout and the Santander advisory fee exclusively on successful business combination consummation, the terms structurally eliminate sponsor compensation risk if the SPAC fails, directly protecting the per-share trust floor from dilution. Furthermore, the forfeiture mechanism tying founder shares to the contingent tontine structure ensures the sponsor absorbs proportional equity dilution relative to public redemptions, mitigating traditional principal-agent conflicts inherent in blank-check offerings. Investors can now precisely model exit liquidity windows and evaluate whether the disclosed strategic pivot toward technology and financial services aligns with their portfolio mandates before separate trading of Class A shares begins.

  • The document governs the precise mechanics for investor liquidity and aligns sponsor and underwriter incentives ahead of the IPO. Management states the company will pursue technology-enabled targets, specifically citing interest in fintech, software, and business services, and notes that according to KPMG there were over 4,500 venture capital, private equity, and M&A fintech deals in 2023. The trust mechanics guarantee that public shareholders will receive their proportionate share of the trust balance calculated as of two business days prior to consummation, while the sponsor waives redemption rights for founder and private placement shares and agrees to indemnify the trust against third-party claims up to the lesser of $10.00 per public share or the actual trust balance. Dilution mechanics are heavily weighted toward the sponsor, as anti-dilution provisions require the conversion ratio to adjust so founder shares automatically equate to exactly 20% of the combined company’s fully diluted ordinary shares post-transaction. Compensation disclosures show Santander US Capital Markets LLC will retain $0.30 per unit in deferred underwriting commissions and receive a separate $6,000,000 advisory fee, both payable exclusively upon business combination closing. Auditor Withum Smith+Brown, PC dates a going concern qualification to January 29, 2025, citing a $563,944 working capital deficiency as of December 31, 2024. Legal counsel Maples and Calder (Cayman) LLP and the prospectus disclose that Cayman Islands law will govern corporate disputes, establishing exclusive jurisdiction in Cayman courts, while no material litigation is currently pending against the registrant or its named officers and directors.

  • These disclosures establish the exact timeline for investor exit options, the baseline trust redemption valuation, and the conditional extension pathway governed by shareholder votes. The sponsor’s $0.004 per share founder share basis, paired with anti-dilution conversion rights targeting a 20% post-offering ownership stake, documents specific economic incentives that management acknowledges could influence deal timing and target selection. The explicit $6,000,000 advisory fee and deferred underwriting compensation introduce additional financial motivations tied to transaction consummation. Furthermore, the disclosed leadership pedigree and sector-focused screening criteria provide the stated operational framework for target evaluation, while the stated going concern qualification underscores the registrant's current reliance on these offering proceeds to sustain operations through the completion window.

  • This registration amendment permanently anchors the SPAC’s structural timeline, liquidity triggers, and incentive matrix before any deal search advances. The fixed 18-to-24-month deadline paired with mandatory pro-rata redemption rights establishes a hard runway that dictates whether the sponsor’s nominal-cost founder equity and the private placement units survive or expire worthless, directly calibrating the sponsor’s incentive to close versus let the trust liquidate. The Company’s explicit declaration of zero target engagement means all future filings will measure execution against this baseline, making any subsequent 10-Q, proxy, or extension proposal immediately comparable to these published terms. The 15% redemption restriction for large holders in proxy-vote scenarios limits outsize blockholder leverage while cementing insider voting control, and the sponsor’s fixed monthly reimbursement and convertible loan terms outline predictable, non-trust-funded operational burn rates that public shareholders can track quarterly. The heavy emphasis on tech, fintech, and business services, backed by named executive track records, frames the universe of potential targets but does not commit the Company to any specific transaction, keeping all mechanical safeguards active until a definitive agreement materializes.

  • Accelerating the registration statement initiates the IPO trading and pricing timeline, which locks the gross proceeds that seed the trust account and activates the standard business combination countdown, thereby defining when shareholders will face future redemption deadlines and extension votes. The correspondence contains no forward-looking claims about target selection, customer contracts, revenue streams, market sizing, technology, partnerships, litigation, or executive personnel; all procedural directives originate solely from the Company, CEO Boon Sim, and the named legal counsel.

  • For redemption and timeline mechanics, the document fixes a strict 24-month completion window from closing, coupled with a statutory extension pathway that requires shareholder approval and triggers fresh redemption rights at the pro rata trust balance. If the deadline passes unmet, automatic liquidation distributes the trust principal (net of permitted working capital withdrawals capped at an annual limit of $800,000 and dissolution costs up to $100,000) back to public shareholders. Deal progress remains zero; the filing explicitly discloses no substantive discussions with targets and imposes a Nasdaq 80% fair market value test to validate future transaction sizing. Regarding sponsor conduct and alignment, the prospectus introduces a unique 'distributable shares' mechanic: a fixed pool of 1,000,000 shares will be pro-rata distributed to non-redeeming public holders at deal close, funded simultaneously by a mandatory forfeiture of an equal number of founder shares by the sponsor. This structures direct counter-incentives against excessive redemptions. Furthermore, the sponsor contractually indemnifies the trust against third-party vendor claims that would otherwise drag the per-share redemption floor below $10.00, while executives face a 180-day lock on public units and a one-year lock on founder shares unless the stock sustains a $12.00 closing price over 20 of 30 trading days post-combination. Strategically, the company’s management and special advisor Ronald Sugar articulate a focused deployment thesis targeting technology-enabled sectors, specifically citing KPMG-reported 2023 fintech deal activity exceeding 4,500 transactions to justify market resilience.

  • These mechanical disclosures materially alter redemption economics and sponsor conduct visibility. By formally acknowledging that working capital and related-party obligations must be financed through permitted withdrawals of trust interest, the filing documents a direct erosion pathway for per-share redemption values, eliminating assumptions that public proceeds will absorb operational burn.

  • According to the prospectus, this structure generates immediate dilution for public investors, as founder shares were acquired at a nominal price and feature anti-dilution provisions designed to maintain a 20% ownership stake post-combination. Management, led by Founder Boon Sim, states a strategic focus on technology-enabled businesses, citing KPMG data that there were over 4,500 venture capital, private equity and M&A fintech deals in 2023. The filing notes material conflicts of interest, as officers and directors hold fiduciary obligations to other entities, including Artius Capital and Fidelis Capital. Financial disclosures show a $241,432 working capital deficiency as of July 31, 2024, accompanied by a going concern explanatory paragraph from auditor Withum Smith+Brown, PC. The prospectus warns that rights expire worthless if no combination occurs within the completion window, and separate trading for Class A ordinary shares and rights commences on the 52nd day following the prospectus date.

  • Regarding other substance, the filing contains no claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel; it functions solely as a regulatory checkpoint on financial disclosures. From an investment perspective, these SEC directives reconfigure expected SPAC economics by explicitly tethering operational viability to trust interest erosion and sponsor debt rather than IPO proceeds.

  • This filing establishes the foundational mechanical framework governing public shareholder liquidity and sponsor incentives for Artius II Acquisition Inc. The hard-coded 24-month expiration window and mandatory pro-rata trust distribution protocol create a definitive deadline that pressures management toward transaction execution or forced dissolution, directly impacting redemption timing and trust yield accrual expectations. The explicit documentation of the sponsor’s $0.004 per share founder share acquisition cost, coupled with forfeiture mechanics and anti-dilution conversion provisions, quantifies the asymmetric economic risk and potential profit margin for insiders independent of public share performance. The contractual obligation to remit $25,000 monthly to an affiliated entity for administrative overhead, alongside the $0.475 per unit deferred underwriting commission structurally erodes net trust capital available for redemptions or post-combination working capital unless offset by trust interest. By formally attaching the investment management trust agreement, contingent rights agreement, and underwriting terms, the filing locks in the distribution waterfall, liquidation priority, and sponsor voting leverage. The going concern qualification tied to the pre-IPO balance sheet underscores the absolute dependency on this offering’s success to fund ongoing operations and meet the stated business combination mandate. The disclosure of over 4,500 recent fintech transactions per KPMG, as cited by management, provides a quantified market backdrop for the stated investment thesis, while the leadership roster anchored by former Credit Suisse executives and a former Northrop Grumman CEO signals the intended operational caliber for future target integration.

  • These updates directly shape investor assessment of sponsor conduct and capital structure flexibility ahead of any merger vote, trust extension, or redemption deadline. The SEC staff flagged governance risks around unilateral sponsor control over foundational equity, and the company’s revised disclosures confirm those structural authorities remain intact while adding transparency. Because the filings are sourced entirely to SEC staff comments, company counsel responses, and a CC to Chief Executive Officer Boon Sim, no external assertions are presented. The document establishes no new trust value, redemption timelines, extension votes, target companies, or financial metrics; it functions purely as a compliance adjustment to align the registration statement with staff expectations. Investors tracking deadline mechanics or redemption pricing should note that this correspondence neither advances nor delays the search window, but does formally lock in disclosed sponsor powers that could influence dilution outcomes or extension negotiations if a deal fails to close.

  • For investors tracking deal progress, redemption positioning, and sponsor alignment, this comment letter signals active SEC scrutiny over how flexibly the sponsor can restructure equity, detach from the SPAC, or compensate board members during the search phase. The mandated risk factor disclosure compels the registrant to publicly acknowledge a pathway for sponsor withdrawal prior to a merger, a development that could alter shareholder calculations before any redemption window opens.

  • The 24-to-27-month deadline rigidly governs the redemption calendar and forces liquidation at the trust balance if unmet, directly determining public shareholder exit liquidity. Extension provisions protect trust value by mandating shareholder votes and cash-out opportunities, but structurally shrink the surviving equity base. Sponsor conduct analysis reveals misaligned incentives: the $0.003 per share founder share acquisition cost positions Artius II Acquisition Partners LLC to realize profits even if public shares depreciate, with the registrant calculating that insider capital would be fully recovered if the trading price settles at $0.324 per share. Personnel disclosures list CEO and CFO Boon Sim, special advisor Ronald Sugar, and independent nominees Karen Richardson, Kevin Costello, and John Stein, attributing a collective track record in technology and finance to the team. Strategy claims center on targeting technology-enabled firms, fintech, software, and business services, with the registrant citing KPMG reporting of over 4,500 venture capital, private equity, and M&A fintech deals in 2023. Financial conditions show a working capital deficiency of $241,432 as of July 31, 2024, with independent auditors Withum Smith+Brown, PC flagging substantial doubt about the company’s ability to continue as a going concern due to minimal pre-offering resources.

  • According to the Company’s response to SEC staff, these revisions directly govern the timeline and conditions under which public shareholders may redeem their shares or vote on extensions, clarifying whether the floor vote can be bypassed and what financial triggers precede trust distribution. The disclosed sponsor economics—particularly the $1.5 million loan conversion pathway, anti-dilution mechanics, and forfeiture contingencies—will materially affect public shareholder equity and voting weight if a transaction closes. The stated implied values of $7.57 and $9.53 establish the Company’s disclosed benchmark for trust-account positioning relative to proposed transaction pricing, informing redemption mathematics. Clarifying that independent directors hold indirect founder share interests through sponsor membership interests ties governance incentives to long-term capital retention rather than short-term liquidation. Because the SEC Staff flagged these items under Regulation S-K Items 1602 and 1603, the finalized prospectus will dictate investor voting rights, disclosure transparency, and regulatory compliance before any redemption deadline or proxy meeting occurs.

  • The SEC’s intervention pauses the S-1 effectiveness timeline, which in turn delays pricing, trust capitalization, and the commencement of the formal redemption period. Because regulators are probing extension permissions, trust preservation conditions, and multiple overlapping financing paths, public investors currently lack confirmed parameters for how long the search can continue before mandatory liquidation, or how heavily sponsor loan conversions and PIPE injections might dilute the trust account prior to a merger.

  • Because the registrant explicitly confirms zero target identification and zero substantive discussions, investor timelines and liquidity events will depend entirely on trust preservation, deadline management, and sponsor execution. The 24-to-27-month completion window establishes a fixed horizon for liquidation redemptions, while the redemption mechanic—where tendered public shares trigger forfeiture of the sponsor’s proportional founder shares and exclude redeeming shareholders from receiving distributable shares—directly ties insider economic outcomes to public participation rates. The registrant itself attributes the sponsor’s nominal $0.003 per share founder share cost and $2,000,000 private placement commitment as creating an incentive structure where insiders could realize substantial profits even if the acquired target declines in value or proves unprofitable for public holders. Additionally, the trust account’s designated permitted withdrawals for working capital (capped at an annual limit of 0.5% of amounts raised) and tax payments, combined with the sponsor’s indemnification pledge to cover third-party claims reducing trust assets below $10.00 per share, define the operational and downside parameters for public shareholder recovery, subject to applicable Cayman Islands law and creditor priority.


Filings

live EDGAR feed

Everything this company has filed with the SEC recently, newest first, each with a plain summary of what changed and why it matters.

  • What changed: Form 8-K Current Report (Item 8.01 Other Events). Per the board of directors and Chief Executive Officer Boon Sim, the company determined it cannot consummate an initial business combination within the timeframe required by its Amended and Restated Memorandum and Articles of Association. The board ordered the immediate cessation of operations (except for winding up), the commencement of liquidation and dissolution proceedings under Cayman Islands law, and the redemption of all outstanding Class A ordinary shares ('Public Shares'). The redemption price per share will be paid in cash, calculated as the aggregate amount in the Trust Account (including interest, net of taxes payable, and less up to $100,000 of interest to fund liquidation and dissolution expenses), divided by the number of then-outstanding Public Shares. This redemption completely extinguishes shareholder rights. Additionally, all rights included in the IPO units will expire worthless, yielding no redemption or liquidating distributions to their holders. Why it matters: This filing terminates the search for a target acquisition and triggers the mandatory trust payout mechanics for public investors. It dictates that Public Shareholders will receive a pro-rata cash distribution from the trust, subject to statutory creditor protections, tax withholdings, and a capped $100,000 withdrawal for dissolution costs. Conversely, rights holders face a total loss with no recourse. Because the exact per-share cash amount depends on the final, uncomputed trust balance at redemption, investors must track subsequent procedural announcements for the record date, filing deadlines, and precise redemption price.

  • What changed: Quarterly Report on Form 10-Q. This Form 10-Q reports that Artius II Acquisition Inc. remains in the target identification phase with no business combination announced. The Trust Account balance stands at $ 232,245,772, reflecting the disclosed per-share redemption value of $ 10.56 for the 22,000,000 outstanding Public Shares. The initial Completion Window expires on August 14, 2026, with a statutory extension to February 14, 2027 contingent on executing a definitive agreement by August 14, 2026. U.S. Treasury securities held in the Trust Account mature on July 23, 2026, requiring imminent reinvestment or liquidation to maintain interest accrual. On March 27, 2026, the Sponsor amended the Working Capital Promissory Note to remove its conversion feature, rendering the $ 900,000 drawn balance (with $ 100,000 available) payable solely in cash. For the six months ended June 30, 2026, General and administrative costs totaled $ 3,356,749 against $ 4,165,986 in interest income, producing a net income of $ 809,237. Operating cash declined to $ 21,231 alongside a working capital deficit of $ 4,547,832. Why it matters: Shareholders face a compressed timeline to the August 14, 2026 liquidation deadline, intensifying pressure on management to demonstrate substantive target diligence before the extension triggers. The July 23, 2026 Treasury maturity creates immediate compliance risk if funds are not rolled over to continue accruing interest for shareholder benefit. Converting the Sponsor Working Capital Loan to cash-only limits potential post-deal dilution from convertible debt but removes equity upside incentives for the Sponsor relative to prior terms. Management’s heavy reliance on $ 4,165,986 in trust interest to cover $ 3,356,749 in H1 2026 operating costs highlights extreme fragility in external liquidity; with only $ 21,231 in operating cash and a $ 4,547,832 working capital deficit, any disruption to interest accrual or unexpected due diligence spend threatens ongoing search operations and triggers the stated going concern warning. Deferred liabilities of $ 6,600,000 (underwriting) and $ 6,000,000 (advisory) remain payable only upon deal completion, aligning sponsor/underwriter payouts with successful execution but underscoring the substantial capital hurdles facing a prospective target acquisition.

    What changed vs 2026-05-06trust $230.1M → $232.2M +1%sponsor loan $300K → $900K
    trust account, sponsor loans outstanding, combination deadline +22 moved · 3 with no prior record of ours
    Trust account
    $230.1M$232.2M

    SpacBrain reads this as $2,104,091 was added to the trust between the two filings.

    The clause “879 188,906 Long-term prepaid insurance ― 14,559 Cash and marketable securities held in Trust Account 232,245,772 228,079,786 Total Assets $ 232,407,651 $ 228,283,251 Liabilities, Class A Shares Subject to Possible Redemption, and”…

    Sponsor loans outstanding
    $300K$900K

    SpacBrain reads this as the sponsor has advanced $600,000 more.

    The clause …“that it is payable solely in cash. As of June 30, 2026, the Company has borrowed $ 900,000 in connection with the Amended and Restated Working Capital Promissory Note and has $ 100,000 available for withdrawal. NOTE 6. COMMITMENTS”…

    Combination deadline
    2026-08-14 · unchanged

    The clause …“14, 2027 if the Company has executed a definitive agreement for an initial business combination by August 14, 2026) (the “Completion Window”) or by such earlier liquidation date as the Company’s board of directors may approve,”…

    Going-concern doubt
    stated · unchanged

    The clause …“year of the issuance of these unaudited condensed financial statements raise substantial doubt about the Company’s ability to continue as a going concern. Management plans to address this uncertainty through an initial business”…

    Redeemable shares
    22.0M · unchanged

    The clause “400,000,000 shares authorized; 175,000 shares issued and outstanding, excluding 22,000,000 shares subject to possible redemption as of June 30, 2026 and December 31, 2025 18 18 Class B Ordinary Shares, $ 0.0001 par value; 50,000,000”…

    Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.

  • What changed: Quarterly report (Form 10-Q) covering operations, financial condition, and liquidity for the quarter ended March 31, 2026. The trust account balance increased to $230,141,681, raising the per-share redemption value to $10.46 from $10.37. The sponsor amended the working capital promissory note on March 27, 2026 to remove its equity conversion feature, making the debt strictly cash-payable, though only $300,000 of the $1,000,000 limit has been utilized. Accrued expenses nearly doubled to $2,856,192, leaving just $20,298 in operating cash against a $3,007,591 working capital deficit. Why it matters: The trust accretion directly increases the maximum potential return for shareholders upon redemption or liquidation. Removing the conversion feature from the working capital debt eliminates future capitalization dilution risk but does not alleviate the severe near-term liquidity gap. With zero operating revenue, a monthly burn rate exceeding $180,000, and a fixed closing deadline of August 14, 2026, these figures heighten the going concern warning and force management to aggressively pursue or secure a definitive business combination agreement before mandatory dissolution triggers.

    What changed vs 2025-11-07trust $225.9M → $230.1M +2%
    trust account, combination deadline, sponsor loans outstanding +21 moved · 4 with no prior record of ours
    Trust account
    $225.9M$230.1M

    SpacBrain reads this as $4,290,250 was added to the trust between the two filings.

    The clause “134 188,906 Long-term prepaid insurance ― 14,559 Cash and marketable securities held in Trust Account 230,141,681 228,079,786 Total Assets $ 230,299,815 $ 228,283,251 Liabilities, Class A Shares Subject to Possible Redemption, and”…

    Combination deadline
    not previously extracted2026-08-14

    The clause …“14, 2027 if the Company has executed a definitive agreement for an initial business combination by August 14, 2026) (the “Completion Window”) or by such earlier liquidation date as the Company’s board of directors may approve,”…

    Sponsor loans outstanding
    not previously extracted$300K

    The clause …“that it is payable solely in cash. As of March 31, 2026, the Company has borrowed $ 300,000 in connection with the Amended and Restated Working Capital Promissory Note and has $ 700,000 available for withdrawal. NOTE 6. COMMITMENTS”…

    Going-concern doubt
    stated · unchanged

    The clause …“year of the issuance of these unaudited condensed financial statements raise substantial doubt about the Company’s ability to continue as a going concern. Management plans to address this uncertainty through an initial business”…

    Redeemable shares
    22.0M · unchanged

    The clause …“400,000,000 shares authorized; 175,000 issued and outstanding, excluding 22,000,000 shares subject to possible redemption as of March 31, 2026 and December 31, 2025 18 18 Class B Shares, $ 0.0001 par value; 50,000,000 shares”…

    Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.

  • What changed: This filing is an SEC Form 8-K reporting the entry into a material definitive agreement amending a working capital promissory note and disclosing a Nasdaq listing compliance extension. Per Item 1.01, the Company and Sponsor amended and restated the original convertible unsecured promissory note issued March 6, 2026, on March 27, 2026, to remove the conversion feature and mandate cash-only repayment. The document states principal remains capped at $1,000,000.00, carries no accrued interest, and matures earlier of business combination closing or liquidation. Per Item 3.01, Nasdaq previously notified the Company on March 6, 2026, of non-compliance with Listing Rule 5452(a)(2)(A) for failing to maintain 300 public holders. Following a plan submission on March 17, 2026, Nasdaq accepted the plan on March 23, 2026, granting an extension until August 31, 2026, to regain compliance. The document notes that missing the August 31, 2026 deadline may trigger delisting, though an appeal stays suspension pending hearing. According to Exhibit 10.1, Section 12 contains a trust waiver where the payee waives all claims against the IPO trust account. Signatories listed in the document are Chief Executive Officer Boon Sim for the Company and Boon Sim, Managing Partner, for Artius II Acquisition Partners LLC. Drawdown mechanics specify minimum increments of $10,000, funded within three business days, with prepaid amounts returning to available borrowing capacity. Why it matters: The conversion feature removal restructures the working capital facility into fixed-cash debt, clarifying payout hierarchy and eliminating equity dilution complications at merger close, while the explicit trust waiver shields public shareholder redemption value from note servicing. However, the Nasdaq extension establishes a rigid August 31, 2026, compliance deadline that runs parallel to the business combination search. As stated in the filing, there is no assurance the Company can repopulate the holder base to 300 public holders by that date, meaning listing suspension risk persists regardless of deal advancement. If delisting occurs before resolution, trading accessibility and liquidity for public warrants and Class A ordinary shares deteriorate. The document confirms active sponsor funding of ongoing operations while highlighting the execution friction between exchange regulatory timelines and SPAC deal progression.

  • What changed: Form 10-K annual report for the fiscal year ended December 31, 2025. According to the filing, the Trust Account balance stood at $228,079,786, establishing a redemption value of $10.37 per public share as of December 31, 2025. The completion window remains August 14, 2026, with an automatic extension to February 14, 2027 contingent on executing a definitive business combination agreement by August 14, 2026. Management reports no target has been identified and discloses a working capital deficit of $1,205,642, noting substantial doubt about continuing as a going concern. A subsequent event details a $1,000,000 convertible unsecured promissory note issued to the Sponsor on March 6, 2026, convertible at $10.00 per 1.1 shares. Why it matters: The $10.37 per-share trust accumulation modestly increases the absolute cash pool for redemptions or a de-SPAC transaction relative to the initial proceeds, but does not change the structural mechanics of the redemption deadline or the voting thresholds. The reported working capital deficit highlights ongoing operational dependency on the Sponsor, reinforced by the newly disclosed $1,000,000 working capital note. Because the audit opinion flags going concern risk against the August 2026 deadline, public shareholders face heightened binary outcomes: either a definitive agreement is signed by mid-2026 to secure the February 2027 extension, or the company proceeds to mandatory liquidation near January 2027. Close attention is warranted on whether management exercises the extension mechanism or faces insolvency pressures from the current deficit.

Show the other 10 filings
  • What changed: Current Report on Form 8-K disclosing a working capital promissory note, creation of a direct financial obligation, unregistered sale of equity securities, and receipt of a Nasdaq listing rule non-compliance notice. On March 6, 2026, Artius II Acquisition Inc. issued a convertible unsecured promissory note to its sponsor, Artius II Acquisition Partners LLC, for up to $1,000,000.00. Executed by Chief Executive Officer Boon Sim, the note accrues no interest and is payable upon the earlier of initial business combination, liquidation, or an Event of Default. At the Sponsor’s election, the unpaid principal converts into Class A ordinary shares calculated by dividing the principal by $10.00, multiplying by 1.1, and rounding up to the nearest whole share. Additionally, Nasdaq notified the Company on March 4, 2026, that it failed to maintain a minimum of 300 public holders of its units and Class A ordinary shares under Listing Rule 5452(a)(2)(A). Nasdaq permits 45 calendar days to submit a compliance plan and up to 180 calendar days to regain conformity. Why it matters: The zero-interest working capital advance preserves the existing $10.56 trust value per share for redemption scenarios by funding operations through sponsor credit, though conversion features create latent dilution upon deal completion or liquidation. The Nasdaq deficiency notice is operationally critical: falling below 300 public holders triggers delisting proceedings that can abruptly curtail the SEARCHING phase. Loss of exchange listing typically forces accelerated redemption timelines, complicates sponsor negotiation leverage, and may require restructuring the business combination process to bypass public market requirements before the 180-day cure period expires.

  • What changed: A Schedule 13G/A beneficial ownership report filed by Polar Asset Management Partners Inc. The filing updates institutional ownership disclosures for AACB. It contains no references to redemption deadlines, trust value, extensions, deal progress, or sponsor conduct. No assertions regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel are attributed to any party, as none are present in the provided text. Zero numerical figures are included in the excerpt, so none are imported, computed, or rounded. Why it matters: Investors and regulators use Schedule 13G/A amendments to track shifts in beneficial ownership and evaluate institutional positioning or strategic intent, though this excerpt signals only a standard compliance update without disclosing share percentages, voting authority, acquisition timelines, or SPAC transaction developments.

  • What changed: A Schedule 13G beneficial ownership report. As stated in the filing, HGC Investment Management Inc. has submitted a Schedule 13G to disclose beneficial ownership. Regarding SPAC mechanics, the document contains no information on redemption deadlines, trust value, extension votes, deal progress, or sponsor conduct. Regarding other substance, the filing contains no claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. Why it matters: Because the submission is strictly an ownership disclosure with no operational, timeline, or fiduciary disclosures attached, it does not influence the mechanics that drive investor redemptions, trust preservation, or business combination deadlines. Sponsor conduct and acquisition momentum remain unchanged by this filing.

  • What changed: Schedule 13G/A — an amendment to a Statement of Beneficial Ownership filed under Section 13(d) of the Securities Exchange Act to report changes in institutional holding positions. The document labels itself as a beneficial ownership report amendment for AACB, submitted by the Healthcare of Ontario Pension Plan Trust Fund. The provided excerpt contains no share counts, ownership percentages, transaction dates, monetary values, or narrative commentary. Accordingly, it discloses no updates to redemption deadlines, trust account distributions, extension proposals, target acquisition progress, or sponsor conduct. Per the filing’s own heading and standard SEC form requirements, this submission records a modification to the named institution’s reported beneficial stake. No claims regarding customers, revenue, market size, corporate strategy, technology, partnerships, litigation, or personnel are present in the text. Why it matters: Investors tracking redemption calendars, trust mechanics, extension timelines, deal advancement, or sponsor behavior will find no structural or chronological adjustments in this filing. Schedule 13G/A amendments document portfolio-level rebalancing by institutional holders rather than corporate catalysts or capital event triggers. While sustained accumulation or divestment by major pension vehicles can inform pre-merger positioning trends, this specific submission neither alters AACB’s statutory redemption window, affects trust-per-share valuations, nor signals sponsorship negotiations. Its sole significance is signaling that an Ontario public pension plan updated its disclosed beneficial ownership stake in the issuer.

  • What changed: Amended Schedule 13G beneficial ownership report. The filing identifies seven Sculptor Capital-affiliated entities—Sculptor Capital LP, Sculptor Capital II LP, Sculptor Capital Holding Corp, Sculptor Capital Holding II LLC, Sculptor Capital Management, Inc., Sculptor Master Fund, Ltd., and Sculptor Special Funding, LP—as joint reporting persons under an amended Schedule 13G. Because the provided excerpt omits share quantities, acquisition dates, ownership percentages, and statement of purpose, the precise amendment to previously filed forms cannot be isolated from this text. Why it matters: Investors tracking Artius II Acquisition Inc.’s redemption deadline, trust distribution mechanics, extension voting, or sponsor conduct cannot extract timing adjustments, conditional commitments, or merger progress indicators from this excerpt. Routine amendments to Schedule 13G filings typically reflect reporting threshold updates, block consolidations, or passive index compliance rather than activist positioning, liquidity engineering, or business combination signaling. Without disclosed share counts or acquisition transactions, the filing provides no measurable evidence of institutional positioning relative to the SPAC’s search phase, nor does it alter trust payout schedules, redemption windows, or sponsor execution obligations.

  • What changed: Form 10-Q quarterly report for the quarter ended September 30, 2025. This is a routine compliance exhibit. The trust account balance is reported at $225,851,431, establishing a per-share redemption value of $10.27. The mandatory liquidation deadline remains August 14, 2026 (extendable to February 14, 2027 upon signing a definitive business combination agreement). No business combination target has been selected. Regarding sponsor conduct and fixed obligations, the company recorded a $6,000,000 advisory fee and maintains an ongoing $25,000 per month administrative services agreement. Non-trust working capital sits at $141,921, triggering going concern language. The entity generates no operating revenue and discloses no new strategy, partnerships, litigation, or personnel changes. Why it matters: This filing updates the financial runway and reaffirms the strict redemption and dissolution timeline without advancing deal progress. The material disclosure centers on the substantial fixed pre-combination costs ($6,000,000 advisory fee plus monthly administrative fees) draining non-trust liquidity, highlighting the financial pressure to secure a de-SPAC transaction before the August 14, 2026 cutoff or face mandatory dissolution.

    What changed vs 2025-08-07trust $223.4M → $225.9M +1%
    trust account, going-concern doubt, redeemable shares1 moved · 2 with no prior record of ours
    Trust account
    $223.4M$225.9M

    SpacBrain reads this as $2,451,396 was added to the trust between the two filings.

    The clause …“51,747 — Deferred offering costs — 503,670 Cash and marketable securities held in Trust Account 225,851,431 — Total Assets $ 226,232,501 $ 503,670 Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and”…

    Going-concern doubt
    stated · unchanged

    The clause …“year of the issuance of these unaudited condensed financial statements raise substantial doubt about the Company’s ability to continue as a going concern. Management plans to address this uncertainty through a Business Combination.”…

    Redeemable shares
    22.0M · unchanged

    The clause …“400,000,000 shares authorized; 175,000 issued and outstanding, excluding 22,000,000 shares subject to possible redemption as of September 30, 2025 and none issued or outstanding as of December 31, 2024 18 — Class B ordinary shares,”…

    Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.

  • What changed: SCHEDULE 13G/A — a routine compliance exhibit amending beneficial ownership disclosures for registered investment advisers and affiliated funds. The excerpted text lists three related filing entities—AQR Capital Management, LLC; AQR Capital Management Holdings, LLC; and AQR Arbitrage, LLC—as submitters of an amended Schedule 13G. The provided text contains no share counts, ownership percentages, acquisition dates, voting or investment power allocations, or stated purposes for the transaction. Consequently, the filing records no reported changes to AACB’s redemption deadline calendar, trust-per-share balance ($10.56), extension vote schedule, business combination pipeline, or sponsor conduct. Why it matters: Filed 13G amendments typically indicate institutional position adjustments, portfolio rebalancing, or threshold recalibrations, but the truncated excerpt lacks the operational pages required to verify actual share movements, control assertions, or tender intentions. No claims regarding customers, revenues, market sizing, strategic direction, technology, partnerships, litigation, or personnel are present in the text. Because no factual assertions or metrics are disclosed in the snippet, no speaker, officer, or third party can be attributed as their source. While the submission confirms that AQR’s arbitration and advisory arms maintain visibility over Artius II Acquisition Inc. during its SEARCHING phase, the absence of quantified holdings or intent language means the filing does not independently shift redemption mechanics, alter trust accounting, trigger extension timelines, or signal deal progress. Investors should await the complete Schedule 13G/A package or accompanying Form 8-K disclosures to determine whether this amendment aligns with aggregate SPAC warrant/certificate trading, proxy scheduling, or sponsor commitment updates.

  • What changed: A Schedule 13G/A amendment filing reporting beneficial ownership of securities in Artius II Acquisition Inc. (AACB), filed on 2025-08-14. The filing updates the beneficial ownership register by listing seven affiliated Sculptor Capital entities (Sculptor Capital LP, Sculptor Capital II LP, Sculptor Capital Holding Corp, Sculptor Capital Holding II LLC, Sculptor Capital Management, Inc., Sculptor Master Fund, Ltd., and Sculptor Special Funding, LP) as reporting persons. It contains no statements regarding AACB’s redemption deadline, trust account distribution mechanics, extension proposals, target acquisition milestones, or changes in sponsor governance or conduct. Why it matters: The document confirms ongoing institutional tracking of AACB by the Sculptor Capital complex, with all ownership attribution derived solely from the listed filers. No substantive business developments, customer relationships, revenue figures, market size estimates, strategic initiatives, technology roadmaps, commercial partnerships, litigation updates, or executive personnel movements are disclosed. The text contains zero numerical data; consequently, no share counts, percentage thresholds, transaction prices, or trust balances appear for calculation, rounding, or application of external valuation conventions.

  • What changed: Form 10-Q quarterly report for the period ended June 30, 2025. Per Note 1, management confirmed the Company has not selected a target and has not engaged in any substantive discussions regarding an initial Business Combination. The Trust Account balance is documented at $223,400,035, representing $10.16 per Public Share. The filing records a $6,000,000 advisory fee and a $6,600,000 deferred underwriting fee. Sponsor administrative support costs incurred totaled $112,500 for the six months ended June 30, 2025. Founder share holdings were adjusted to 5,500,000 following underwriter-related forfeitures. Working Capital Loans remain at zero. Why it matters: The explicit statement of zero substantive discussions keeps the standard 18-month completion window (terminating approximately August 14, 2026) active without extension mechanisms, maintaining full redemption clock pressure. The documented trust value of $10.16 per share sets the precise baseline for public shareholder redemptions and reflects realized interest accretion since the February 14, 2025 IPO. The recording of a $6,000,000 advisory fee and $6,600,000 deferred underwriting obligation materially increases fixed payout burdens; these commitments reduce future liquidity available for acquisitions or intensify potential redemption outflows. The combination of zero deal progress, high deferred compensation, and a filed going concern warning signals heavy reliance on executing a transaction before operating runway depletes.

    What changed vs 2025-05-07trust $221.1M → $223.4M +1%
    trust account, going-concern doubt, redeemable shares1 moved · 2 with no prior record of ours
    Trust account
    $221.1M$223.4M

    SpacBrain reads this as $2,326,596 was added to the trust between the two filings.

    The clause …“88,934 — Deferred offering costs — 503,670 Cash and marketable securities held in Trust Account 223,400,035 — Total Assets $ 223,948,762 $ 503,670 Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and”…

    Going-concern doubt
    stated · unchanged

    The clause …“acceptable terms, if at all. The Company’s liquidity condition raises substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after the date that the accompanying”…

    Redeemable shares
    22.0M · unchanged

    The clause …“400,000,000 shares authorized; 175,000 issued and outstanding, excluding 22,000,000 shares subject to possible redemption as of June 30, 2025 and none issued or outstanding as of December 31, 2024 18 — Class B ordinary shares, $”…

    Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.

  • What changed: Schedule 13G beneficial ownership report. The Schedule 13G identifies Polar Asset Management Partners Inc. as a reporting beneficial owner of Artius II Acquisition Inc. (AACB) securities. Per the filing text, it discloses no alterations to the SPAC’s operational mechanics: the trust value ($10.56 per share), the August 14, 2026 search deadline, and the current SEARCHING status remain unaffected. The filing reports no updates to redemption capacity, extension voting procedures, business combination timelines, or sponsor governance arrangements. Why it matters: As a routine SEC compliance exhibit, the filing tracks institutional shareholding rather than acquisition progress. Because the provided excerpt omits the mandatory ownership table (aggregate shares held, percentage of outstanding equity, acquisition dates, and purchase prices), investors cannot determine whether Polar Asset Management Partners Inc. recently crossed a 5% reporting threshold, adjusted its position at prices aligned with or divergent from the $10.56 trust value, or modified its stance ahead of the August 14, 2026 deadline. The submission contains no claims regarding potential target companies, customer concentrations, revenue projections, market sizing, strategic roadmaps, technology portfolios, partnership structures, litigation matters, or personnel appointments, and therefore carries no direct weight on trust liquidity, redemption mechanics, deal execution, or sponsor conduct.


The record

The reference detail — how the shares were structured at listing, how thinly they trade, and where the company is registered.

Show the reference detail

Unit structure

Cash in trust at IPO$10.00

That was the figure at listing. It is $10.56 a share today — interest on the account, plus any sponsor payments made to extend the deadline, spread over the shares that never cashed out. Unit: U = S + R/10 · 100.0% of the $10 unit

from 424B4 0001140361-25-004482

Unit quote (AACBU)$10.70

as of 21 August 2026

Right quote (AACBR)$0.01

as of 19 August 2026

Trading & liquidity

Average daily volume (20d)197K
Average daily $ volume$2.1M
Range over the bars held$10.53 – $10.59
Total cash in trust$232.2M

Company profile

Industry (SIC)Blank Checks (6770)
Registered inthe Cayman Islands
Exchange · CIKNasdaq · 0002034334

All filings on EDGARopens on sec.gov in a new tab

Directors & officers


Institutional holders

from SC 13G/13D

Funds that have declared a stake above 5%. Heavy ownership by arbitrage funds usually means heavy cash-outs at the next vote.

Show the declared stakes

8 filers with a stake on file · 4 re-affirmed in the last 12 months. A stake with no amendment since is the filer’s last word on it, not proof it is still held — and percentages filed in different years are percentages of different floats, because this vehicle’s share count collapses at every redemption.

One line per filer, not per reporting person: a joint schedule names the management company, its funds and often the individual who controls them, and all of them report the same shares. Click a name for that filer’s whole footprint across every SPAC it has declared a stake in.


Sources on file

harvested pages, kept in full

Every public page we have read about this company, stored in full so a source can never go missing.

Show the sources

38 full SEC filing texts archived — searchable, never lost.


Cash in trust over time

XBRL, per filing

How much cash has stood behind each share at each filing date.

Show the filed values
  • 30 June 2026$10.56
  • 30 June 2026

In plain English

tap a term to open it

Every piece of jargon this page could have used, and what it actually means.

Open the plain-English guide
No floor / floorlessthe cash guarantee is gone — the price is unprotected

A SPAC's downside protection is not the cash in trust; it is your right to demand that cash. Once the redemption window closes, the cash stays with the company and the share can trade anywhere.

Redemption deadlinethe last day to hand shares back for cash

Set by the filing that calls the meeting. Tender after it and the company is under no obligation to pay you the trust value.

Broker action datethe day your broker needs the instruction — earlier than the official date

Brokers batch redemption instructions to the transfer agent, so the practical cutoff is roughly two business days before the published deadline. This is the date that actually costs people the floor.

Cash in trust / trust per sharethe cash the company is holding for each public share

Filed quarterly in the 10-Q's XBRL. It earns interest between filings, so the figure on a given day is slightly higher than the last filed one — where we show that we label it an estimate.

Trust discountbuying below the cash held for you

Only meaningful while a redemption right exists. On a floorless name the same arithmetic is not a discount, it is the market pricing distress, and this product will not call it a yield.

Dilutionhow much of the company new shares take from you

Sponsor promote, PIPE shares, warrants and rights all issue stock that did not pay $10 for it. The headline deal value is before that; the effective value is after.

Pro-forma equitywhat the company is valued at once the deal closes

The combined company's equity value assuming the announced terms and the redemptions that have actually happened.

ARShow much upside you get per unit of downside

SpacBrain's asymmetric-return score. It is deterministic — the same inputs always produce the same number — and it is capped, not zeroed, when the floor is gone.

De-SPACthe day the SPAC becomes the real company

The shares stop being a claim on a pot of cash and start being equity in an operating business. Roughly 80% of recent de-SPACs traded below $10 within a year.

Outside datethe contractual long-stop for closing the deal

A deadline between the SPAC and its target, not between the SPAC and you. It confers no right to cash, which is exactly why it must never be counted as a redemption window.

Accession numberthe SEC's unique id for one filing

Every figure on this page carries the accession of the filing that states it, so you can open the primary document rather than trust us.

Accreted NAV (estimate)the last filed cash figure, plus the interest it should have earned since

A model, not a filing: last filed value compounded at the 3-month T-bill for the days elapsed. Always shown in italic with the word estimate, and never printed beside a filed number without it.


Ask the brain

from its filings
Data provenance & audit trail2 internal entries

Written by SpacBrain’s data agents whenever a figure is captured, corrected or flagged, and kept verbatim so every number on this page can be traced back to the filing that states it. This is a running log, not the current record: an early entry may be superseded by a later correction — the panels above always hold the current values.

AACB — company record
UNIVERSE2026-08-14

Admitted from orphan-filing sweep. Blank check: SIC 6770 (EDGAR). Ticker AACB (AACBU, rights AACBR), Nasdaq, from Q2-2026 10-Q cover (filed 2026-08-05, primary ef20075495_10q.htm). IPO 2025-02-14: 22,000,000 units, gross $220,000,000; trust $220,000,000 = $10.00/unit (10-Q). No 425/S-4 and no definitive agreement in Q2-2026 10-Q -> SEARCHING. Sponsor not cleanly stated -> null. Missing for downstream: quotes, deadline, sponsor entity, people, summaries.

SPONSOR-NAME2026-08-24

Artius II Acquisition Partners LLC — read from 10-K 0001140361-26-010274: "● “Sponsor” means Artius II Acquisition Partners LLC, a Delaware limited liability company, in its capacity as the sponsor of Artius II." · [LIFECYCLE 2026-08-13 · 0001140361-26-032643] LIQUIDATING per 8-K (effective 2026-08-13) — "On August 13, 2026, the board of directors of Artius II Acquisition Inc. (the “Company”) determined that the Company will not be able to consummate an initial business combination within the time period required by the Company’s Amended and"